This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Northwestern University. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Leo I. Gordon: Innovator in Drug Delivery Systems
Introduction
Leo I. Gordon is a notable inventor based in Winnetka, IL (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on lipophilic nanoparticles. His research focuses on enhancing the efficacy of therapeutic agents, which has important implications for treating various diseases.
Latest Patents
Leo I. Gordon holds a patent for "Lipophilic nanoparticles for drug delivery." This patent describes nanostructures that consist of a core, a lipid layer, and a lipoprotein, which are designed to deliver therapeutic agents effectively. The methods outlined in his patent include treating diseases such as cancer, infectious diseases, and vascular diseases, showcasing the potential of his innovations in medical applications.
Career Highlights
Leo I. Gordon is affiliated with Northwestern University, where he continues to advance his research in nanotechnology and drug delivery systems. His work has garnered attention for its potential to revolutionize how therapeutic agents are administered and absorbed in the body.
Collaborations
Leo has collaborated with esteemed colleagues, including C. Shad Thaxton and Raja Kannan Mutharasan. These partnerships have contributed to the development and refinement of his innovative approaches in the field.
Conclusion
In summary, Leo I. Gordon is a pioneering inventor whose work on lipophilic nanoparticles is paving the way for advancements in drug delivery systems. His contributions are vital for improving treatment methods for various diseases, highlighting the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
